Home › Companies › REGENXBIO Inc. › 2025-2026
Compiled from SEC Form N-PX filings and REGENXBIO Inc.’s Form 8-K, filed 2026-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore REGENXBIO Inc. in the interactive database Compare manager voting policies
These tallies are REGENXBIO Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jean Bennett, M.D., Ph.D. | 24,025,836 | -- | -- | 11,238,926 | 7,554,121 | Majority: yes |
| Elect Director: A.N. "Jerry" Karabelas, Ph.D. | 27,124,923 | -- | -- | 8,139,839 | 7,554,121 | Majority: yes |
| Elect Director: Daniel Tassé | 32,039,753 | -- | -- | 3,225,009 | 7,554,121 | Majority: yes |
| Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026: | 42,526,553 | 244,785 | 47,545 | -- | 0 | Majority: yes |
| Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement: | 32,392,302 | 2,722,825 | 149,635 | -- | 7,554,121 | Majority: yes |
| Proposal 4: By the following vote, the stockholders approved, the Stock Option Exchange Program for the Company's non-executive employees: | 26,352,456 | 8,853,230 | 59,076 | -- | 7,554,121 | Majority: yes |
| Proposal 5: By the following vote, the stockholders did not approve, a Stock Option Exchange Program for the Company's executive employees: | 14,097,815 | 21,021,531 | 145,416 | -- | 7,554,121 | Majority: no |
Source: REGENXBIO Inc., Form 8-K, filed with the SEC on 2026-06-03 — read the filing on EDGAR.
Each item below shows how the 178 asset managers that disclosed a REGENXBIO Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENXBIO Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”): 32,392,302 for, 2,722,825 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 63% for, 5% against (68% of the company cast a for/against vote).
The 178 asset managers below cast 99.3% of the shares they voted on this item FOR (28,636,000 for, 182,079 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,372,242 | 11,543 | 0 | 0 | For |
| Redmile Group, LLC | 4,368,804 | 0 | 0 | 0 | For |
| Vanguard | 3,362,533 | 7 | 0 | 0 | For |
| State Street | 2,399,945 | 3,368 | 0 | 0 | For |
| JPMorgan | 2,053,043 | 0 | 0 | 0 | For |
| Fidelity | 1,702,911 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,137,498 | 0 | 0 | 0 | For |
| Invesco | 918,311 | 0 | 0 | 0 | For |
| Charles Schwab | 781,105 | 0 | 0 | 0 | For |
| AQR | 780,600 | 0 | 0 | 0 | For |
| Nuveen | 582,109 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 451,007 | 0 | 0 | 0 | For |
| Dimensional | 434,553 | 0 | 0 | 0 | For |
| Goldman Sachs | 397,989 | 0 | 0 | 0 | For |
| Integral Health Asset Management, LLC | 315,769 | 0 | 0 | 0 | For |
| Voss Capital, LP | 295,787 | 0 | 0 | 0 | For |
| Northern Trust | 220,140 | 1,455 | 0 | 0 | For |
| ArchPoint Investors | 215,197 | 0 | 0 | 0 | For |
| Kintegral Advisory, LLC | 201,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| DE Shaw | 151,857 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 149,000 | 0 | 0 | 0 | For |
| Two Sigma | 145,349 | 0 | 0 | 0 | For |
Showing the 25 largest of 178 asset managers. See all 178 in the interactive database.
Combines 2 wordings of this item as funds reported it.
46.3% fund support · no official result
The 58 asset managers below cast 46.3% of the shares they voted on this item FOR (5,916,446 for, 6,854,066 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,837 | 31,110 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 0 | 2,050,372 | 0 | 0 | Against |
| State Street | 1,198 | 1,560,055 | 0 | 0 | Against |
| Fidelity | 0 | 1,399,543 | 0 | 0 | Against |
| TIAA | 0 | 567,096 | 0 | 0 | Against |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 342,335 | 0 | 0 | Against |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 149,000 | 0 | 0 | Against |
| Equitable | 0 | 113,520 | 0 | 0 | Against |
| MFS | 0 | 93,369 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 79,442 | 0 | 0 | Against |
| Brighthouse | 47,885 | 26,895 | 0 | 0 | For |
| Lincoln Financial | 26,317 | 37,171 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 61,836 | 0 | 0 | Against |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 42,108 | 0 | 0 | Against |
| Northern Trust | 0 | 30,712 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 29,212 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 26,809 | 0 | 0 | Against |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 7 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Elect Director: A.N. "Jerry" Karabelas, Ph.D.”): 27,124,923 for, 8,139,839 withheld, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 52.6% for, 16% withheld (68% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (12,325,319 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,021,945 | 0 | 6,001 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,559,242 | 0 | 2,011 | 0 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 342,335 | 0 | Abstain |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 67,490 | 0 | 46,030 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| Brighthouse | 63,281 | 0 | 11,499 | 0 | For |
| Lincoln Financial | 58,417 | 0 | 5,071 | 0 | For |
| AIG/SunAmerica | 61,836 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 9 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Elect Director: Daniel Tassé”): 32,039,753 for, 3,225,009 withheld, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 62% for, 6% withheld (68% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (12,327,311 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,023,878 | 0 | 8 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,559,302 | 0 | 1,951 | 0 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 342,335 | 0 | Abstain |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 67,490 | 0 | 46,030 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| Brighthouse | 63,281 | 0 | 11,499 | 0 | For |
| Lincoln Financial | 58,417 | 0 | 5,071 | 0 | For |
| AIG/SunAmerica | 61,836 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 6 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Elect Director: Jean Bennett, M.D., Ph.D.”): 24,025,836 for, 11,238,926 withheld, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 46.5% for, 22% withheld (68% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (11,726,819 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,858 | 0 | 31,089 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,557,594 | 0 | 3,659 | 0 | For |
| Fidelity | 1,372,143 | 0 | 27,400 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 342,335 | 0 | Abstain |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 149,000 | 0 | Abstain |
| Equitable | 67,490 | 0 | 46,030 | 0 | For |
| MFS | 0 | 0 | 93,369 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| Brighthouse | 47,885 | 0 | 26,895 | 0 | For |
| Lincoln Financial | 58,417 | 0 | 5,071 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 61,836 | 0 | Abstain |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 42,108 | 0 | Abstain |
| Northern Trust | 0 | 0 | 30,712 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 29,212 | 0 | Abstain |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 25,779 | 0 | Abstain |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
75% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Proposal 4: By the following vote, the stockholders approved, the Stock Option Exchange Program for the Company's non-executive employees:”): 26,352,456 for, 8,853,230 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 51.1% for, 17% against (68% of the company cast a for/against vote).
The 57 asset managers below cast 73% of the shares they voted on this item FOR (9,267,571 for, 3,494,223 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,864 | 31,082 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,198 | 1,560,055 | 0 | 0 | Against |
| Fidelity | 403,601 | 995,942 | 0 | 0 | Against |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 342,335 | 0 | 0 | Against |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 149,000 | 0 | 0 | Against |
| Equitable | 67,490 | 46,030 | 0 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| Brighthouse | 47,885 | 26,895 | 0 | 0 | For |
| Lincoln Financial | 26,317 | 37,171 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 61,836 | 0 | 0 | Against |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 42,108 | 0 | 0 | Against |
| Northern Trust | 0 | 30,712 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 29,212 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
99.4% Majority: yes · of votes cast
REGENXBIO Inc.’s own tally for this item (“Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”): 42,526,553 for, 244,785 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,617,000 outstanding shares: 82% for, 0.5% against (83% of the company cast a for/against vote).
The 57 asset managers below cast 99.9% of the shares they voted on this item FOR (12,750,235 for, 59 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,027,945 | 0 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,561,194 | 59 | 0 | 0 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 342,335 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 113,520 | 0 | 0 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| Brighthouse | 63,281 | 0 | 11,499 | 0 | For |
| Lincoln Financial | 63,488 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 61,836 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Ranked by the number of REGENXBIO Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 51,617,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 8.49% |
| 2 | Redmile Group, LLC | 8.46% |
| 3 | Vanguard | 6.51% |
| 4 | State Street | 4.66% |
| 5 | JPMorgan | 3.98% |
| 6 | Fidelity | 3.30% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.20% |
| 8 | Invesco | 1.78% |
| 9 | Charles Schwab | 1.51% |
| 10 | AQR | 1.51% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 11.20% | 13F |
| Redmile Group, LLC | 10.07% | DEF14A |
| JPMorgan Chase | 6.75% | 13F |
| Vanguard Group | 6.54% | 13F |
| Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company | 5.58% | DEF14A |
| State Street | 5.29% | 13F |
| Morgan Stanley | 3.90% | 13F |
| Goldman Sachs | 3.56% | 13F |
| Geode Capital | 2.20% | 13F |
| AQR Capital | 2.04% | 13F |
Percentages above are of 51,617,000 shares outstanding, as reported by REGENXBIO Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At REGENXBIO Inc.'s shareholder meeting held 2026-05-29, in the 2025-2026 proxy season, 178 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,491 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation paid to the Company's executive employees. — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: REGENXBIO Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-03.
REGENXBIO Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).